BioKos - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 84,377 | 120,280 | 232,073 | 310,869 | 304,507 | 342,420 | 299,480 | 321,946 |
| Profit before tax | 1,963 | - | - | - | - | - | - | - |
| Net profit | 1,963 | -16,373 | 27,217 | 9,143 | 3,648 | -17,072 | 21,396 | -3,793 |
| Equity | 24,066 | 7,693 | 37,999 | 32,289 | 31,231 | 14,159 | 35,554 | 31,761 |
| Liabilities | 10,579 | 16,492 | 22,155 | 23,825 | 26,705 | 32,627 | 6,547 | 9,159 |
| Non-current assets | 16,018 | 16,376 | 14,773 | 12,206 | 14,205 | 10,907 | 1,954 | 1,630 |
| Current assets | 18,627 | 7,911 | 45,084 | 42,786 | 42,867 | 35,343 | 39,736 | 39,493 |
| Total assets | 34,645 | 24,287 | 59,857 | 54,992 | 57,072 | 46,250 | 41,690 | 41,123 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 25,338 | 24,767 | 25,427 |
| Social insurance contributions | - | - | - | - | - | 15,943 | 1,645 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +41.3% | +42.6% | +92.9% | +34.0% | -2.0% | +12.5% | -12.5% | +7.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.7% | -67.4% | 45.5% | 16.6% | 6.4% | -36.9% | 51.3% | -9.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 8.2% | -212.8% | 71.6% | 28.3% | 11.7% | -120.6% | 60.2% | -11.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.3% | -13.6% | 11.7% | 2.9% | 1.2% | -5.0% | 7.1% | -1.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.3% | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 2.1 | 0.6 | 0.7 | 0.9 | 2.3 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 17,764 | 17,390 | 38,679 | 59,213 | 87,002 | 54,787 | 99,827 | 154,537 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BioKos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-09-17 | 2024-09-22 | 737.98 |
| 2023-11-16 | 2023-12-14 | 1.29 |
| 2023-10-26 | 2023-11-14 | 1.29 |
| 2023-10-25 | 2023-10-25 | 9.15 |
| 2023-08-17 | 2023-08-21 | 1438.68 |
| 2023-07-28 | 2023-08-15 | 14.68 |
| 2023-07-24 | 2023-07-25 | 15.15 |
| 2023-06-16 | 2023-06-18 | 1299.12 |
| 2023-04-18 | 2023-04-19 | 1348.84 |
| 2023-02-17 | 2023-03-15 | 0.17 |
| 2023-02-06 | 2023-02-14 | 0.17 |
| 2023-01-24 | 2023-02-03 | 0.17 |
| 2023-01-20 | 2023-01-22 | 0.17 |
| 2022-11-17 | 2022-11-18 | 188.76 |
| 2022-05-17 | 2022-06-14 | 0.49 |
| 2022-04-28 | 2022-05-15 | 0.49 |
| 2022-03-16 | 2022-04-14 | 0.29 |
| 2022-02-17 | 2022-03-14 | 0.29 |
| 2022-01-31 | 2022-02-14 | 0.29 |
| 2022-01-18 | 2022-01-19 | 547.57 |
| 2021-11-05 | 2021-12-06 | 2.81 |
| 2021-09-16 | 2021-09-26 | 1041.48 |
BioKos - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-25 | 2026-07-26 | 29.0 |
| 2026-04-30 | 2026-05-25 | 0.31 |
| 2026-04-23 | 2026-04-23 | 29.03 |
| 2026-03-29 | 2026-04-22 | 0.03 |
| 2025-10-02 | 2025-10-24 | 0.45 |
| 2025-07-24 | 2025-07-25 | 0.76 |
| 2025-07-01 | 2025-07-23 | 2.38 |
| 2025-04-26 | 2025-04-26 | 474.77 |
| 2025-03-02 | 2025-03-06 | 5.72 |
| 2025-02-28 | 2025-03-01 | 0.72 |
| 2025-02-26 | 2025-02-26 | 662.0 |
| 2025-01-30 | 2025-02-25 | 1.0 |
| 2025-01-01 | 2025-01-24 | 0.65 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BioKos, UAB (code 302655922) is a Private Limited Liability Company engaged in other non-specialised retail sale. In 2025, the company generated revenue of EUR 321.9K, up 7.5% year on year, but still 6.0% below the 2023 level. Net profit for 2025 was a loss of EUR 3.8K, compared with a profit of EUR 21.4K in 2024 and a loss of EUR 17.1K in 2023, showing a volatile but recent weakening in profitability. The 2025 profit margin was -1.2%. At year-end 2025, total assets stood at EUR 41.1K, equity at EUR 31.8K, and liabilities at EUR 9.2K. The balance sheet remains conservative, with an equity ratio of 77.2% and debt-to-equity of 0.29. Asset turnover was 7.83x, indicating relatively strong revenue generation from the asset base. Revenue per employee was EUR 161.0K, while profit per employee was EUR -1.9K.